Anstee DJ, Cartron J (1997). Toward an understanding of the red cell surface. in Applications of molecular biology to blood transfusion medicine.(ed. Garratty G), Bethesda: American Association of Blood Banks, pp.17-49

Review Articles

Avent ND (1997). Immunochemistry and protein chemistry of the Rh polypeptides in normal and variant phenotype erythrocytes. Biotest Bulletin 5, 415-428

Avent ND (1997). Human Blood group antigen expression: Its molecular bases. Brit J Biomed Sci 54, 16-37

Avent ND (1997). Prenatal determination of fetal Rh status using the PCR. Biotest Bulletin 5, 429-438

Daniels GL (1997). Coordinators report: antibodies to Lutheran, Kell, Duffy, Kidd, and Jra antigens. Transfus Clin Biol 4, 99-103

Daniels GL (1997). Kell and Duffy blood group sytems. Bol Soc Hematol Hemot Special Supplement, 61-65

Daniels GL (1997). Blood group polymorphisms: molecular approach and biological significance. Transfus Clin Biol 4, 383-390

Daniels GL (1997). Lutheran, Kidd, and Diego blood group systems. Bol Soc Hematol Hemot Special Supplement, 57-60

Daniels GL (1997). Molecular biology in immunohaematology. Bol Soc Hematol Hemot Special Supplement, 37-40

Daniels GL (1997). Unusual blood group phenotypes. Bol Soc Hematol Hemot Special Supplement, 69-72

Daniels GL (1997). Low frequency antigens associated with Rh: markers for genetic variants. Biotest Bulletin 5, 399-407

Daniels GL, Green CA, Petty AC (1997). Antibodies to complement regulatory proteins. Transfusion Clin Biol 4, 127-129

Jones JW, Voak D, Scott ML, Sonneborn HH (1997). Policies for the selection of monoclonal RhD typing reagents. Biotest Bulletin 5, 485-494

Kumpel BM (1997). Monoclonal anti-D for prophylaxis of RhD haemolytic disease of the newborn. Transfus Clin Biol 4, 351-356

Kumpel BM (1997). Monoclonal prophylactic anti-D. Biotest Bulletin 5, 511-514

Scott ML, Voak D, Jones JW, Liu W, Avent ND, Hughes Jones NC, Sonneborn HH (1997). A model for RhD - the relationship of 30 serologically defined epitopes to structure. Biotest Bulletin 5, 459-466

Smythe JS, Anstee DJ (1997). Expression of Rh genes and site directed mutagenesis. Biotest Bulletin 5, 467-473

Sonneborn HH, Ernst M, Voak D, Scott ML (1997). Monoclonal antibodies in research and diagnosis of Rh-system antigens. Biotest Bulletin 5, 475-483

Original Articles

Avent ND, Jones JW, Liu W, Scott ML, Voak D, Flegel WA, Wagner F, Green CA (1997). Molecular basis of the D variant phenotypes DNU and DII allows localization of critical amino acids required for expression of Rh D epitopes epD3, 4 and 9 to the sixth external domain of the Rh D protein. Brit J Haematol 97, 366-371

Avent ND, Liu W, Jones JW, Scott ML, Voak D, Pisacka M, Watt J, Fletcher A (1997). Molecular analysis of Rh transcripts and polypeptides from individuals expressing the DVI variant phenotype: A RHD gene deletion event does not generate all DVIccEe phenotypes. Blood 89, 1779-1786

Clarke E, Potter MN, Oakhill A, Cornish JM, Stewart CG, Pamphilon DH (1997) A laboratory comparison of T-cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: clinical implications for bone marrow transplantation and donor leukocyte therapy. Bone Marrow Transplant 20, 599-605.

Goodrick J, Hadley AG, Poole GD (1997). Haemolytic disease of the fetus and newborn due to anti-Fya and the potential value of Duffy genotyping in pregnancies at risk. Transfus Med 7, 301-304

Hadley AG, Poole J, Poole GD (1997). The clinical significance of anti-G in alloimmunized pregnancies. Transfusion 37, 985

Huang CH, Blumenfeld OO, Reid ME, Chen Y, Daniels GL, Smart E (1997). Alternative splicing of a novel glycophorin allele GPHe(GL) generates two protein isoforms in the human erythrocyte membrane. Blood 90, 391-397

Jackson DJ, Kumpel BM (1997). Optimisation of human anti-tetanus toxoid antibody responses and location of human cells in SCID mice transplanted with human peripheral blood leucocytes. Hum Antibodies 8, 181-188

Johnson P, Daniels GL (1997). A mutation analysis on GYPC, the gene encoding the Gerbich blood group antigens. Transfus Med 7, 239-244

Jones JW, Finning KM, Mattock R, Williams M, Voak D, Scott ML, Avent ND (1997). The serological profile and molecular basis of a new partial D phenotype, DHR. Vox Sang 73, 252-256

King M, Kosanke J, Reid ME, Poole J, Banks J, Hemming NJ, Smythe JS, Martin PG (1997). Co-presence of a point mutation and a deletion of exon 3 in the glycophorin C gene and concomitant production of a Ge-related antibody. Transfusion 37, 1027-1034

Kumpel BM (1997). In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D. Vox Sang 72, 45-51

Lucas GF, Pittman SJ, Davies S, Solanki T, Brugemann K (1997). Post-transfusion purpura association with anti-HPA-1a, anti-HPA-2b and anti-HPA-3a antibodies. Transfus Med 7, 295-299

Parsons SF, Mallinson G, Daniels GL, Green CA, Smythe JS, Anstee DJ (1997). Use of domain-deletion mutants to locate Lutheran blood group antigens to each of the five immunoglobulin superfamily domains of the Lutheran glycoprotein: elucidation of the molecular basis of the Lua/Lub and the Aua/Aub polymorphisms. Blood 89, 4219-4225

Petty AC, Green CA, Daniels GL (1997). The monoclonal antibody-specific immobilisation of erythrocyte antigens assay (MAIEA) in the investigation of human red cell antigens and their associated membrane proteins. Transfus Med 7, 179-188

Petty AC, Green CA, Poole J, Daniels GL (1997). Analysis of Knops blood group antigens on CR1 (CD35) by the MAIEA test and by immunoblotting. Transfus Med 7, 55-62

Rider JR, Ollier WER, Lock RJ, Brookes ST, Pamphilon DH (1997) Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 15, 405-409

Shepard SL, Hadley AG (1997). Monocyte-bound monoclonal antibodies inhibit the FcgRI-mediated phagocytosis of red cells: the efficiency and mechanism of inhibition are determined by the nature of the antigen. Immunology 90, 314-322

Snowden JA, Poole J, Bates AJ, Faulkner M, Day V, Booker DJ, Sokol RJ, Reilly JT (1997). The Rhnull phenotype in an English individual: Haematological , serological and immunochemical studies. Clin Lab Haematol 19, 143-148

Spring FA, Holmes CH, Simpson KL, Mawby WJ, Mattes MJ, Okubo Y, Parsons SF (1997). The Oka blood group antigen is a marker for the M6 leukocyte activation antigen, the human homolog of OX-47 antigen, basigin and neurothelin, an immunoglobulin superfamily molecule that is widely expressed in human cells and tissues. Eur J Immunol 27, 891-897

Thorpe SJ, Boult CE, Stevenson FK, Scott ML, Sutherland J, Spellerberg MB, Natvig JB, Thompson KM (1997). Cold agglutinin activity is common amongst human monoclonal IgM anti-Rh antibodies using the V4-34 heavy chain variable gene segment. Transfusion 37, 1111-1116

Wallace M, Lomas-Francis C, Beckers EAM, Bruce M, Campbell G, Chatfield S, Nagao N, Okubo Y, Opalka A, Overbeeke M, et al. (1997). DBT: a partial D phenotype assocaited with the low incidence antigen Rh32. Transfus Med 7, 233-238

Wickramasinghe SN, Hasan R, Smythe JS (1997). Reduced interferon-alpha production by Epstein-Barr virus transformed B-lymphoblastoid cell lines and lectin -stimulated lymphocytes in congenital dyserythropoietic anaemia type 1. Brit J Haematol 98, 295-298

Letters

Scott ML, Voak D Detection of acquired B antigen by monoclonal anti-B blood grouping reagents. Transfusion. (1997). 37, 103

Published Abstracts

Avent ND, Daniels GL, Martin PG, Green CA, Finning KM, Warner KM (1997) Molecular investigation of the Rh C/c polymorphism. Transfus Med 7, 18

Daniels GL, Green CA, Avent ND, Smart E, Faas BH, Maaskant-van Wijk PA, van der Schoot CE (1997) The VS and V polymorphisms in Black South Africans. Transfusion 101S,

Daniels GL, Green CA, Mallinson G, Okubo Y, Hori Y, Kataoka A, Kaihara M (1997) Decay-accelerating factor (CD55) deficiency phenotypes in Japanese. Transfus Med 7, 17

Daniels GL, Green CA, Powell R (1997) Cromer antibodies: analysis with soluble recombinant decay-accelerating factor (srDAF) and the monoclonal antibody immobilization of erythrocyte antigens assay (MAIEA). Transfusion 37, (Suppl. 88S)

Hadley AG, Goodrick J, Penman D, Wilkes A, Lucas GF, Webster R, DeGiorgi R, Brearley R, Soothill P (1997) The role of the chemiluminescence test in the clinical management of pregnancies at risk of HDN. Transfus Med 7, (Suppl. 1) 30

Hadley AG, Wilkes A, Poole J (1997) A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med 7, (Suppl. 1) 29

Lee D, Austin E, Kumpel BM, Jackson DJ, Judson PA, Howarth J, Chapman GE (1997) Comparison of flow cytometric and 51Cr assays for estimation of red cell clearance in vivo. Transfus Med 7, 28

Lloyd-Evans P, Gilmour JEM (1997) Expression of recombinant IgG1 and IgG3 forms of an antibody which neutralise varicella zoster virus. Transfusion 37, 18S

Mallinson G, Green CA, Okubo Y, Daniels GL (1997) The molecular background of recessive Lu(ab) phenotype in a Japanese family. Transfus Med 7, 18

Manoussaka MS, Kumpel BM, Sooranna SR (1997) Characterisation of term trophoblast cells in culture. Placenta 18, 37

Manoussaka MS, Whittle CJ, Kumpel BM, Mathieson PW (1997) Isolation and characterisation of human term trophoblasts. Immunology 92, 70

Montgomery W, Nance S, Kavitsky D, Molina N, Moulds M, Olivares E, Deasis E, Daniels GL (1997) First example of hemolytic disease of the newborn (HDN) due to an antibody to a high incidence antigen present on multiple cell lines (MCL). Transfusion 37, (Suppl.) 41S

Olsson ML, Hansson C, Akesson IE, Avent ND, Daniels GL (1997) Detection of the common alleles at the Duffy blood group locus by allele-specific primer PCR. [Abstract] Transfusion 37, (Suppl.) 102S

Poole J, Banks J, Kjeldsen-Kragh J, King M, Hansen T, Vetlesen A, Hustinx H (1997) Second example of MiV/MiV phenotype with anti-Wrb : A case study. Transfus Med 7, 24

Poole J, Hallewell H, Bruce L, Tanner MJ, Zupanska B, Kusnierz-Alejska G (1997) Identification of two new Jn(a+) individuals and assignment of Jna to erythrocyte band 3. Transfusion 37, (9S) S358

Powell H, Moody S, Gooch A, Shwe KH, Howarth J, Lucas GF, Hadley AG, Poole J, Wilkes A (1997) Chemiluminescence test and red cell survival studies in a case of anti-JMH. Transfus Med 7, (Suppl.1) 30

Rankin A, Goodyear E, Scott ML, Ouwehand WH (1997) Minor cell population analysis in Rh D negative women by flow cytometry using FITC labelled IgG-BRAD-3 - A comparative study on 2000 samples. Transfus Med 7, (S1) 27

Rogers S, Lucas GF (1997) Detection of antibodies to platelet GpIb/IX using a solid phase platelet antibody kit. Transfus Med 7, 33

Scott ML, Guest AG, Rodkey LS (1997) Cytoskeletal extracts from Triton X-100 treated red cell membrane preparations show Rh and Jk blood group activity. Transfus Med 7, (Suppl.1) 29

Smythe JS, Anstee DJ (1997) K562 cells expressing Rh D polypeptide with a Cys 285 to Ala mutation have normal D antigen. Transfus Med 7, (Suppl. 1) 29

Southcott MJG, Parsons SF, Anstee DJ, Tanner MJ (1997) Lutheran glycoprotein, a cell adhesion molecule that binds laminin with high affinity, is expressed on late erythrocyte precursors and appears after Band 3. Blood 90, (Supplement 1) 175b

Voak D, Scott ML, Jones JW, Sonneborn HH (1997) Rh D in practice. Infusionstherapie und Transfusionsmedizin 24, 258